Animal testing has played a critical role in the development of drugs, enabling us to ultimately obtain data which serves as a foundation to be able to deliver safe and effective drugs to patients. We are an AAALAC accredited organization committed to the 3Rs, by reducing the number of animals used, maintaining the well-being of animal models and offering other in vitro alternatives to model disease.
FELASA, the Federation of European Laboratory Animal Science Associations, also emphasizes the use of the 3Rs, advocating responsible scientific conduct when using animals. With ‘communication’ as a motto, The FELASA Congress is a great opportunity to share ideas and exchange knowledge in all fields of laboratory animal science.
InnoSer is invested in providing not only the infrastructure and equipment necessary to support you in expanding your research pipeline, but also customized services to fit your scientific needs. For instance, we provide flexible room rental options with access to advanced analysis systems, along with administrative, technical, and scientific support. The IACUC and veterinary assistance within our in vivo preclinical studies can ensure support on animal welfare, breeding and ethical regulatory permission.
Facility Management and Support
Contract Breeding
Colony management services ensure your small rodent colonies are maintained or expanded under reliable and transparent conditions that meet SPF and SOPF standards and animal welfare guidelines. Our team of experts handles the calculations of your study design, takes full control of the preparation and follows through with breeding.
Genetically engineered models
Cryopreservation and rederivation services protect your mouse lines, reduce the number of animals needed to maintain a breeding colony and keep their microbiological statuses under control.
In vivo disease models
- ADPKD
- PDX, syngeneic, orthotopic tumor models
- Heart failure (Ang II, MI, TAC)
- NASH model
- Duchenne muscular dystrophy
- AD mouse models
- Immunization studies
In addition to these flexible support options, we offer other preclinical research offerings such as safety testing, PK/PD/ADME studies and therapeutic efficacy testing. These services can be combined with the room rental options to create an optimal environment to conduct your experiments.
Would you like to hear more about the full scope of our facility management and support services? Then feel free to reach out to our BDM Pascal Simoens at the FELASA congress. In the meantime, you can find an overview of our offerings at https://www.innoserlaboratories.com/services/. See you soon!
Want to read more?
Novel Translational Readout: Auditory Event-Related Potentials EEG-Recording in Fragile X Syndrome Model
Fragile X Syndrome Fragile X syndrome is caused by mutations of the FMR1 gene, leading to loss of functional fragile x mental retardation protein (FMRP). FXS is characterised by delays in neurodevelopmental milestones, autistic behaviour, anxiety, and cognitive...
Accelerating ALS Drug Development: InnoSer’s Available In Vivo Models for Preclinical Research
Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disorder lacking highly effective disease-modifying treatment or a cure. The often-heterogenous course of ALS underlines the need for modelling the different disease aspects in multiple, distinct models...
In Vitro & In Vivo Parkinson’s Disease Models: Understanding Their Role in Preclinical Drug Development
Parkinson’s disease (PD) is a complex neurodegenerative disorder that affects millions of people worldwide. Different experimental models recapitulate distinct pathophysiological features of PD. Selecting the most appropriate model for a specific research question is...